RADEK SKODA to Drug Therapy, Combination
This is a "connection" page, showing publications RADEK SKODA has written about Drug Therapy, Combination.
Connection Strength
0.019
-
JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report. Acta Haematol. 2013; 129(1):23-5.
Score: 0.019